{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:29:56Z","timestamp":1793910596334,"version":"4.8.0"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.expneurol.2025.115167","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:07:52Z","timestamp":1738080472000},"page":"115167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Targeting the NLRP3 inflammasome in Parkinson's disease: From molecular mechanism to therapeutic strategy"],"prefix":"10.1016","volume":"386","author":[{"given":"Jin-Yu","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Mei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.expneurol.2025.115167_bb0005","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/ars.2014.5994","article-title":"Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?","volume":"22","author":"Abais","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"6431","key":"10.1016\/j.expneurol.2025.115167_bb0010","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8657","article-title":"cGAS in action: expanding roles in immunity and inflammation","volume":"363","author":"Ablasser","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2025.115167_bb0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbi.2020.09.017","article-title":"Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease","volume":"91","author":"Ahmed","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12974-023-02830-w","article-title":"Pharmacologic inhibition of NLRP3 reduces the levels of alpha-synuclein and protects dopaminergic neurons in a model of Parkinson\u2019s disease","volume":"20","author":"Amo-Aparicio","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2025.115167_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.trsl.2022.08.006","article-title":"NLRP3 inflammasome in neurodegenerative disease","volume":"252","author":"Anderson","year":"2023","journal-title":"Transl. Res."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115167_bb0030","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nri3921","article-title":"STING: infection, inflammation and cancer","volume":"15","author":"Barber","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-5728(99)00176-9","article-title":"Dopamine, a neurotransmitter, influences the immune system","volume":"102","author":"Basu","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0045","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.1100613","article-title":"Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome","volume":"187","author":"Bauernfeind","year":"2011","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115167_bb0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cell.2022.01.009","article-title":"An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity","volume":"185","author":"Borriello","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2025.115167_bb0055","series-title":"A small molecule inhibitor of Caspase 1, in Probe Reports from the NIH Molecular Libraries Program","author":"Boxer","year":"2010"},{"issue":"6455","key":"10.1016\/j.expneurol.2025.115167_bb0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.expneurol.2025.115167_bb0065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2025.115167_bb0070","doi-asserted-by":"crossref","unstructured":"Burre, J., M. Sharma, and T.C. Sudhof, Cell Biology and Pathophysiology of Alpha-Synuclein. Cold Spring Harb Perspect Med, 2018. vol. 8(3).","DOI":"10.1101\/cshperspect.a024091"},{"key":"10.1016\/j.expneurol.2025.115167_bb0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neuroscience.2018.07.019","article-title":"Long noncoding RNA SNHG1 promotes Neuroinflammation in Parkinson\u2019s disease via regulating miR-7\/NLRP3 pathway","volume":"388","author":"Cao","year":"2018","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.expneurol.2025.115167_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jez.662","article-title":"Regulatory volume decrease and P receptor signaling in fish cells: mechanisms, physiology, and modeling approaches","volume":"315","author":"Chara","year":"2011","journal-title":"J. Exp. Zool. A Ecol. Genet. Physiol."},{"key":"10.1016\/j.expneurol.2025.115167_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577089","article-title":"Inflammasome and alpha-synuclein in Parkinson\u2019s disease: a cross-sectional study","volume":"338","author":"Chatterjee","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"7734","key":"10.1016\/j.expneurol.2025.115167_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-018-0761-3","article-title":"PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation","volume":"564","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.expneurol.2025.115167_bb0095","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2025.115167_bb0100","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuro.2017.12.001","article-title":"LncRNA SNHG1 promotes alpha-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells","volume":"68","author":"Chen","year":"2018","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12974-021-02349-y","article-title":"p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson\u2019s disease","volume":"18","author":"Chen","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.expneurol.2025.115167_bb0110","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41423-021-00683-y","article-title":"RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor","volume":"18","author":"Chen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.expneurol.2025.115167_bb0115","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cell.2007.11.028","article-title":"Calcium signaling","volume":"131","author":"Clapham","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115167_bb0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.expneurol.2025.115167_bb0125","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2025.115167_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11010-014-2207-z","article-title":"Glutamate 85 and glutamate 228 contribute to the pH-response of the soluble form of chloride intracellular channel 1","volume":"398","author":"Cross","year":"2015","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.expneurol.2025.115167_bb0135","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1074\/jbc.M608083200","article-title":"ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages","volume":"282","author":"Cruz","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"376","key":"10.1016\/j.expneurol.2025.115167_bb0140","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","article-title":"Activation of MyD88-dependent TLR1\/2 signaling by misfolded alpha-synuclein, a protein linked to neurodegenerative disorders","volume":"8","author":"Daniele","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.expneurol.2025.115167_bb0145","doi-asserted-by":"crossref","first-page":"12504","DOI":"10.1038\/ncomms12504","article-title":"Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models","volume":"7","author":"Daniels","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2025.115167_bb0150","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-beta and cognitive function in APP\/PS1 mice","volume":"61","author":"Dempsey","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.immuni.2018.04.032","article-title":"The TWIK2 potassium Efflux Channel in macrophages mediates NLRP3 Inflammasome-induced inflammation","volume":"49","author":"Di","year":"2018","journal-title":"Immunity"},{"issue":"5876","key":"10.1016\/j.expneurol.2025.115167_bb0160","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.expneurol.2025.115167_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006510","article-title":"Malarial hemozoin is a Nalp3 inflammasome activating danger signal","volume":"4","author":"Dostert","year":"2009","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.expneurol.2025.115167_bb0170","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/glia.24174","article-title":"The two pore potassium channel THIK-1 regulates NLRP3 inflammasome activation","volume":"70","author":"Drinkall","year":"2022","journal-title":"Glia"},{"issue":"7293","key":"10.1016\/j.expneurol.2025.115167_bb0175","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.expneurol.2025.115167_bb0180","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1073\/pnas.0611496104","article-title":"Cryopyrin\/NALP3 binds ATP\/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling","volume":"104","author":"Duncan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.expneurol.2025.115167_bb0185","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1007\/s12035-015-9620-5","article-title":"MicroRNA-7 enhances subventricular zone neurogenesis by inhibiting NLRP3\/Caspase-1 Axis in adult neural stem cells","volume":"53","author":"Fan","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","article-title":"Systemic activation of NLRP3 inflammasome and plasma alpha-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease","volume":"17","author":"Fan","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0195","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1038\/s41467-018-06449-x","article-title":"Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer\u2019s disease mouse model","volume":"9","author":"Flores","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ncb2012","article-title":"PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1","volume":"12","author":"Geisler","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"465","key":"10.1016\/j.expneurol.2025.115167_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"40","key":"10.1016\/j.expneurol.2025.115167_bb0210","doi-asserted-by":"crossref","first-page":"E9371","DOI":"10.1073\/pnas.1812744115","article-title":"Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming","volume":"115","author":"Green","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115167_bb0215","first-page":"184","article-title":"Serial bone-scan changes in recurrent bone infarction","volume":"17","author":"Greyson","year":"1976","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115167_bb0220","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","article-title":"K(+) efflux-independent NLRP3 Inflammasome activation by small molecules targeting mitochondria","volume":"45","author":"Gross","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.expneurol.2025.115167_bb0225","doi-asserted-by":"crossref","first-page":"1161606","DOI":"10.3389\/fimmu.2023.1161606","article-title":"Pattern-recognition receptors in endometriosis: a narrative review","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115167_bb0230","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.expneurol.2025.115167_bb0235","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","article-title":"Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease","volume":"15","author":"Han","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2025.115167_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101911","article-title":"Kaempferol alleviates LD-mitochondrial damage by promoting autophagy: implications in Parkinson\u2019s disease","volume":"41","author":"Han","year":"2021","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.expneurol.2025.115167_bb0245","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/ana.410440612","article-title":"Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals","volume":"44","author":"Hattori","year":"1998","journal-title":"Ann. Neurol."},{"issue":"7590","key":"10.1016\/j.expneurol.2025.115167_bb0250","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0255","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"issue":"7434","key":"10.1016\/j.expneurol.2025.115167_bb0260","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.expneurol.2025.115167_bb0265","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.it.2014.02.007","article-title":"Calcium signaling and mitochondrial destabilization in the triggering of the NLRP3 inflammasome","volume":"35","author":"Horng","year":"2014","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115167_bb0270","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2025.115167_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577543","article-title":"A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson\u2019s disease","volume":"354","author":"Huang","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2025.115167_bb0280","first-page":"12","article-title":"Endosomal trafficking of two-pore K(+) efflux channel TWIK2 to plasmalemma mediates NLRP3 inflammasome activation and inflammatory injury","author":"Huang","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2025.115167_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115735","article-title":"The interplay between alpha-Synuclein and NLRP3 inflammasome in Parkinson\u2019s disease","volume":"168","author":"Huang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"11","key":"10.1016\/j.expneurol.2025.115167_bb0295","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1089\/neu.2017.5344","article-title":"MCC950, the selective inhibitor of nucleotide oligomerization domain-like receptor Protein-3 Inflammasome, protects mice against traumatic brain injury","volume":"35","author":"Ismael","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"12","key":"10.1016\/j.expneurol.2025.115167_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122565","article-title":"Pathological functions of LRRK2 in Parkinson\u2019s disease","volume":"9","author":"Jeong","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.expneurol.2025.115167_bb0305","doi-asserted-by":"crossref","first-page":"E330","DOI":"10.1097\/BRS.0000000000001287","article-title":"Dopamine D1 receptor agonist A-68930 inhibits NLRP3 Inflammasome activation, controls inflammation, and alleviates histopathology in a rat model of spinal cord injury","volume":"41","author":"Jiang","year":"2016","journal-title":"Spine (Phila Pa 1976)"},{"issue":"11","key":"10.1016\/j.expneurol.2025.115167_bb0310","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.expneurol.2025.115167_bb0315","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","article-title":"Anti-inflammatory compounds parthenolide and bay 11-7082 are direct inhibitors of the inflammasome","volume":"285","author":"Juliana","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"31","key":"10.1016\/j.expneurol.2025.115167_bb0320","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1073\/pnas.0906277106","article-title":"Repression of alpha-synuclein expression and toxicity by microRNA-7","volume":"106","author":"Junn","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7081","key":"10.1016\/j.expneurol.2025.115167_bb0325","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature04517","article-title":"Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin\/Nalp3","volume":"440","author":"Kanneganti","year":"2006","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.expneurol.2025.115167_bb0330","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.4049\/jimmunol.1402658","article-title":"K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling","volume":"194","author":"Katsnelson","year":"2015","journal-title":"J. Immunol."},{"issue":"6676","key":"10.1016\/j.expneurol.2025.115167_bb0335","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.expneurol.2025.115167_bb0340","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"7427","key":"10.1016\/j.expneurol.2025.115167_bb0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature11588","article-title":"The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP","volume":"492","author":"Lee","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0350","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","article-title":"MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson\u2019s disease by targeting Nlrp3","volume":"31","author":"Li","year":"2018","journal-title":"Hum. Cell"},{"issue":"13","key":"10.1016\/j.expneurol.2025.115167_bb0355","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1016\/j.celrep.2020.02.105","article-title":"SFTSV infection induces BAK\/BAX-dependent mitochondrial DNA release to trigger NLRP3 Inflammasome activation","volume":"30","author":"Li","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2025.115167_bb0360","article-title":"Targeting microglial alpha-Synuclein\/TLRs\/NF-kappaB\/NLRP3 Inflammasome Axis in Parkinson\u2019s disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2025.115167_bb0365","first-page":"4608914","article-title":"Attenuation of ROS\/chloride efflux-mediated NLRP3 Inflammasome activation contributes to alleviation of diabetic cardiomyopathy in rats after sleeve gastrectomy","volume":"2022","author":"Li","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.expneurol.2025.115167_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.expneurol.2025.115167_bb0375","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.it.2021.07.005","article-title":"Lipid regulation of NLRP3 inflammasome activity through organelle stress","volume":"42","author":"Liang","year":"2021","journal-title":"Trends Immunol."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115167_bb0380","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.4161\/cc.24903","article-title":"Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death","volume":"12","author":"Lima","year":"2013","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0385","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1567202613666160316155228","article-title":"Long non-coding RNA HOTAIR promotes Parkinson\u2019s disease induced by MPTP through up-regulating the expression of LRRK2","volume":"13","author":"Liu","year":"2016","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.expneurol.2025.115167_bb0390","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.molimm.2018.09.010","article-title":"The role of mitochondria in NLRP3 inflammasome activation","volume":"103","author":"Liu","year":"2018","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115167_bb0395","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2025.115167_bb0400","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0405","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuron.2017.12.002","article-title":"Microglial ramification, surveillance, and interleukin-1beta release are regulated by the two-pore domain K(+) channel THIK-1","volume":"97","author":"Madry","year":"2018","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.expneurol.2025.115167_bb0410","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a beta-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2025.115167_bb0415","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.semcdb.2021.12.009","article-title":"Ubiquitin-mediated mechanisms of translational control","volume":"132","author":"Martinez-Ferriz","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115167_bb0420","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202003053","article-title":"ASC oligomer favors caspase-1CARD domain recruitment after intracellular potassium efflux","volume":"222","author":"Martin-Sanchez","year":"2023","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.expneurol.2025.115167_bb0425","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115167_bb0430","first-page":"588","article-title":"Localization of a gene for an autosomal recessive form of juvenile parkinsonism to chromosome 6q25.2-27","volume":"60","author":"Matsumine","year":"1997","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0435","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0304-4165(87)90072-9","article-title":"Isolation and characterisation of goat C-reactive protein","volume":"924","author":"Maudsley","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0440","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1038\/s41467-021-24784-4","article-title":"Chloride sensing by WNK1 regulates NLRP3 inflammasome activation and pyroptosis","volume":"12","author":"Mayes-Hopfinger","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.expneurol.2025.115167_bb0445","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"Alpha-Synuclein misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"issue":"45","key":"10.1016\/j.expneurol.2025.115167_bb0450","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1523\/JNEUROSCI.2431-08.2008","article-title":"CLIC1 function is required for beta-amyloid-induced generation of reactive oxygen species by microglia","volume":"28","author":"Milton","year":"2008","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2025.115167_bb0455","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41590-022-01192-4","article-title":"Caspase-11 interaction with NLRP3 potentiates the noncanonical activation of the NLRP3 inflammasome","volume":"23","author":"Moretti","year":"2022","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115167_bb0460","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/glia.23337","article-title":"Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop","volume":"66","author":"Mouton-Liger","year":"2018","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.expneurol.2025.115167_bb0465","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Munoz-Planillo","year":"2013","journal-title":"Immunity"},{"issue":"28","key":"10.1016\/j.expneurol.2025.115167_bb0470","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.1117765109","article-title":"Critical role for calcium mobilization in activation of the NLRP3 inflammasome","volume":"109","author":"Murakami","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115167_bb0475","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.expneurol.2025.115167_bb0480","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115167_bb0485","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000298","article-title":"PINK1 is selectively stabilized on impaired mitochondria to activate Parkin","volume":"8","author":"Narendra","year":"2010","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115167_bb0495","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3233\/JPD-223290","article-title":"Role of NLRP3 Inflammasome in Parkinson\u2019s disease and therapeutic considerations","volume":"12","author":"Nguyen","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0500","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10571-016-0373-0","article-title":"Investigation of long non-coding RNA expression profiles in the substantia Nigra of Parkinson\u2019s disease","volume":"37","author":"Ni","year":"2017","journal-title":"Cell. Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115167_bb0505","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4049\/jimmunol.1500509","article-title":"Multiple Cathepsins promote pro-IL-1beta synthesis and NLRP3-mediated IL-1beta activation","volume":"195","author":"Orlowski","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115167_bb0510","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s12035-020-02198-5","article-title":"NLRP3 Inflammasome inhibition prevents alpha-Synuclein pathology by relieving autophagy dysfunction in chronic MPTP-treated NLRP3 knockout mice","volume":"58","author":"Ou","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115167_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.expneurol.2025.115167_bb0520","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1084\/jem.20182191","article-title":"Fyn kinase regulates misfolded alpha-synuclein uptake and NLRP3 inflammasome activation in microglia","volume":"216","author":"Panicker","year":"2019","journal-title":"J. Exp. Med."},{"issue":"15","key":"10.1016\/j.expneurol.2025.115167_bb0525","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","article-title":"Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease","volume":"110","author":"Panicker","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2025.115167_bb0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-8977-10-3","article-title":"Silica induces NLRP3 inflammasome activation in human lung epithelial cells","volume":"10","author":"Peeters","year":"2013","journal-title":"Part. Fibre Toxicol."},{"issue":"21","key":"10.1016\/j.expneurol.2025.115167_bb0535","doi-asserted-by":"crossref","first-page":"15195","DOI":"10.1016\/S0021-9258(17)36591-2","article-title":"Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity","volume":"269","author":"Perregaux","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115167_bb0540","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.4049\/jimmunol.149.4.1294","article-title":"IL-1 beta maturation: evidence that mature cytokine formation can be induced specifically by nigericin","volume":"149","author":"Perregaux","year":"1992","journal-title":"J. Immunol."},{"issue":"48","key":"10.1016\/j.expneurol.2025.115167_bb0545","doi-asserted-by":"crossref","first-page":"40201","DOI":"10.1074\/jbc.M505186200","article-title":"Identification of a novel extracellular cation-sensing G-protein-coupled receptor","volume":"280","author":"Pi","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115167_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26040953","article-title":"The role of the Inflammasome in neurodegenerative diseases","volume":"26","author":"Piancone","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0555","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.expneurol.2025.115167_bb0560","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/pharmrev.120.000189","article-title":"Parkinson disease: translating insights from molecular mechanisms to neuroprotection","volume":"73","author":"Pirooznia","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115167_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/ph14080717","article-title":"Current therapies in clinical trials of Parkinson\u2019s disease: a 2021 update","volume":"14","author":"Prasad","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.expneurol.2025.115167_bb0570","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.bi.45.070176.002441","article-title":"Biological applications of ionophores","volume":"45","author":"Pressman","year":"1976","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.expneurol.2025.115167_bb0575","first-page":"5","article-title":"Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation","author":"Prochnicki","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.expneurol.2025.115167_bb0580","doi-asserted-by":"crossref","first-page":"8151836","DOI":"10.1155\/2019\/8151836","article-title":"Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia\/Reoxygenation-induced injury through activating ROS-dependent NLRP3 Inflammasome-mediated Pyroptosis in H9C2 cardiomyocytes","volume":"2019","author":"Qiu","year":"2019","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0585","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","article-title":"PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation","volume":"8","author":"Quinn","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115167_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajamaki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2025.115167_bb0595","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2022.04.076","article-title":"MCC950 ameliorates the dementia symptom at the early age of line M83 mouse and reduces hippocampal alpha-synuclein accumulation","volume":"611","author":"Ren","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2025.115167_bb0600","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ncomms2339","article-title":"Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors","volume":"3","author":"Rossol","year":"2012","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115167_bb0605","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4049\/jimmunol.2100035","article-title":"Microglial NLRP3 Inflammasome activation upon TLR2 and TLR5 ligation by distinct alpha-Synuclein assemblies","volume":"207","author":"Scheiblich","year":"2021","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115167_bb0610","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.immuni.2022.10.021","article-title":"IKKbeta primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network","volume":"55","author":"Schmacke","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0615","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1074\/jbc.C115.700492","article-title":"A genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 Inflammasome activation","volume":"291","author":"Schmid-Burgk","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0620","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41531-024-00744-9","article-title":"Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson's disease pathogenesis","volume":"10","author":"Senkevich","year":"2024","journal-title":"NPJ Parkins. Dis."},{"issue":"7761","key":"10.1016\/j.expneurol.2025.115167_bb0625","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.expneurol.2025.115167_bb0630","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2025.115167_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110990","article-title":"Uric acid aggravates myocardial ischemia-reperfusion injury via ROS\/NLRP3 pyroptosis pathway","volume":"133","author":"Shen","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115167_bb0640","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115167_bb0645","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/77060","article-title":"Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase","volume":"25","author":"Shimura","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2025.115167_bb0650","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson\u2019s disease: genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"5","key":"10.1016\/j.expneurol.2025.115167_bb0655","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1529\/biophysj.105.072678","article-title":"Redox regulation of CLIC1 by cysteine residues associated with the putative channel pore","volume":"90","author":"Singh","year":"2006","journal-title":"Biophys. J."},{"issue":"10","key":"10.1016\/j.expneurol.2025.115167_bb0660","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.tins.2023.07.009","article-title":"Inflammasome assembly in neurodegenerative diseases","volume":"46","author":"Singh","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2025.115167_bb0665","doi-asserted-by":"crossref","first-page":"13727","DOI":"10.1038\/ncomms13727","article-title":"The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3","volume":"7","author":"Song","year":"2016","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115167_bb0670","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41419-021-04420-1","article-title":"Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases","volume":"12","author":"Soriano-Teruel","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1\u20134","key":"10.1016\/j.expneurol.2025.115167_bb0675","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1152\/advan.00034.2004","article-title":"Cellular volume homeostasis","volume":"28","author":"Strange","year":"2004","journal-title":"Adv. Physiol. Educ."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0680","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12974-020-01988-x","article-title":"Low-density lipoprotein receptor (LDLR) regulates NLRP3-mediated neuronal pyroptosis following cerebral ischemia\/reperfusion injury","volume":"17","author":"Sun","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2025.115167_bb0685","doi-asserted-by":"crossref","first-page":"1019365","DOI":"10.3389\/fimmu.2022.1019365","article-title":"Kynurenic acid ameliorates NLRP3 inflammasome activation by blocking calcium mobilization via GPR35","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"issue":"5262","key":"10.1016\/j.expneurol.2025.115167_bb0690","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.272.5262.735","article-title":"The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)","volume":"272","author":"Surprenant","year":"1996","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.expneurol.2025.115167_bb0695","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0700","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41467-017-00227-x","article-title":"CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation","volume":"8","author":"Tang","year":"2017","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.expneurol.2025.115167_bb0705","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025847118","article-title":"Soluble alpha-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia","volume":"118","author":"Trudler","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115167_bb0710","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115167_bb0715","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/319522","article-title":"Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36","volume":"68","author":"Valente","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"5674","key":"10.1016\/j.expneurol.2025.115167_bb0720","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2025.115167_bb0725","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-018-0061-5","article-title":"NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease","volume":"4","author":"von Herrmann","year":"2018","journal-title":"NPJ Parkins. Dis."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115167_bb0730","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/j.1460-2075.1995.tb07149.x","article-title":"Potassium-inhibited processing of IL-1 beta in human monocytes","volume":"14","author":"Walev","year":"1995","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115167_bb0735","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1007\/s12035-016-9793-6","article-title":"The role of long noncoding RNAs in neurodegenerative diseases","volume":"54","author":"Wan","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115167_bb0740","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ajmg.b.32410","article-title":"Association of four new candidate genetic variants with Parkinson\u2019s disease in a Han Chinese population","volume":"171B","author":"Wang","year":"2016","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"15","key":"10.1016\/j.expneurol.2025.115167_bb0745","doi-asserted-by":"crossref","first-page":"24449","DOI":"10.18632\/oncotarget.15511","article-title":"The long noncoding RNA HOTAIR promotes Parkinson's disease by upregulating LRRK2 expression","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.expneurol.2025.115167_bb0750","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0755","first-page":"931","article-title":"Alpha-synuclein promotes progression of Parkinson\u2019s disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome","volume":"19","author":"Wang","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115167_bb0760","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3164\/jcbn.22-122","article-title":"Knockdown of LRRK2 inhibits the progression of lung cancer by regulating TLR4\/NF-kappaB pathways and NLRP3 inflammasome","volume":"73","author":"Wu","year":"2023","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115167_bb0765","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.bbrc.2018.08.089","article-title":"The selective Nlrp3 inflammasome inhibitor Mcc950 attenuates lung ischemia-reperfusion injury","volume":"503","author":"Xu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2025.115167_bb0770","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0775","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s12035-022-03134-5","article-title":"Chronic microcystin-LR-induced alpha-Synuclein promotes Neuroinflammation through activation of the NLRP3 Inflammasome in microglia","volume":"60","author":"Yan","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.expneurol.2025.115167_bb0780","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13834","article-title":"Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease","volume":"22","author":"Yan","year":"2023","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0785","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13238-021-00888-x","article-title":"PINK1 kinase dysfunction triggers neurodegeneration in the primate brain without impacting mitochondrial homeostasis","volume":"13","author":"Yang","year":"2022","journal-title":"Protein Cell"},{"issue":"10","key":"10.1016\/j.expneurol.2025.115167_bb0790","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.277","article-title":"K(+) regulates ca(2+) to drive inflammasome signaling: dynamic visualization of ion flux in live cells","volume":"6","author":"Yaron","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.expneurol.2025.115167_bb0795","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 Inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115167_bb0800","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s12276-022-00729-9","article-title":"Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis","volume":"54","author":"Zhang","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"7717","key":"10.1016\/j.expneurol.2025.115167_bb0805","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasome activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"issue":"7329","key":"10.1016\/j.expneurol.2025.115167_bb0810","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2025.115167_bb0815","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 targets nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"11","key":"10.1016\/j.expneurol.2025.115167_bb0820","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41418-018-0127-2","article-title":"Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of beta-arrestin2 and NLRP3","volume":"25","author":"Zhu","year":"2018","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115167_bb0825","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115167_bb0830","doi-asserted-by":"crossref","first-page":"13793","DOI":"10.1038\/s41598-020-70236-2","article-title":"Effect of kaempferol on the transgenic Drosophila model of Parkinson\u2019s disease","volume":"10","author":"Rahul","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625000317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625000317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T15:24:49Z","timestamp":1740669889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625000317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":166,"alternative-id":["S0014488625000317"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115167","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the NLRP3 inflammasome in Parkinson's disease: From molecular mechanism to therapeutic strategy","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115167"}}